COVID-19 Progression in End-Stage Kidney Disease

NCT04495907 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 412

Last updated 2022-03-22

No results posted yet for this study

Summary

The purpose of this study is to collect genomic and clinical data among a cohort of hemodialysis patients and analyze the association between genetic markers and the development and severity of illness in response to SARS-CoV-2.

Conditions

  • SARS-CoV-2 Infection (Asymptomatic)
  • SARS-CoV-2 Infection (Symptomatic)

Sponsors & Collaborators

  • Davita Clinical Research

    lead INDUSTRY

Principal Investigators

  • Jeffrey Connaire, MD · Davita Clinical Research

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-06
Primary Completion
2021-04-09
Completion
2021-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04495907 on ClinicalTrials.gov